Phase I Study of HSK46575 in Patients With Metastatic Castration-Resistant Prostate Cancer

NCT07007910 · clinicaltrials.gov ↗

PHASE1

Phase

RECRUITING

Status

90

Enrollment

INDUSTRY

Sponsor class

Conditions

m CRPC

Interventions

DRUG: HSK46575

Sponsor

Haisco Pharmaceutical Group Co., Ltd.